National Graphite Corp.

$0.04+37.04%(+$0.01)
TickerSpark Score
49/100
Weak
50
Valuation
40
Profitability
20
Growth
36
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NGRC research report →

52-Week Range62% of range
Low $0.02
Current $0.04
High $0.05

Companywww.nationalgraphite.com

National Graphite Corp. , through its subsidiary, Biotech Development Corp. , operates as a biopharmaceutical risk/cost-sharing company.

CEO
Mrs. Ulrike Dickmann
IPO
2012
Employees
1
HQ
Duesseldorf, DE

Price Chart

-13.95% · this period
$0.05$0.03$0.02May 19Nov 17May 19

Valuation

Market Cap
$5.71M
P/E
-107.25
P/S
0.00
P/B
-2.61
EV/EBITDA
-170.07
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
4.67%
ROIC
72.53%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-53,235 · 0.00%
EPS
$0.00 · 0.00%
Op Income
$-46,035
FCF YoY
0.00%

Performance & Tape

52W High
$0.05
52W Low
$0.02
50D MA
$0.03
200D MA
$0.03
Beta
-1.41
Avg Volume
639

Get TickerSpark's AI analysis on NGRC

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our NGRC Coverage

We haven't published any research on NGRC yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate NGRC Report →

Similar Companies